Prajapati Sudeep

发表

H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies

M. Warmuth, O. Abdel-Wahab, B. Caleb, 2016 .

Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWTand ERaMUTbreast cancer

M. Hao, M. Warmuth, M. Korpal, 2021 .